Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients
C. Perez(University of Geneva), İlker Uçkay(University of Zurich), Pierre Hoffmeyer(Swiss National Science Foundation), Mathieu Assal(University of Geneva), Daniel Lew(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Louis Bernard(Université Paris Cité)
Cited by 52
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
|Diabetes/Metabolism Research and Reviews|2023|283
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263